Addus HomeCare Corporation logo

Addus HomeCare Corporation (ADUS)

Market Open
16 Oct, 04:11 PM
NASDAQ (NGS) NASDAQ (NGS)
$
116. 67
+0.18
+0.1563%
$
2.18B Market Cap
- P/E Ratio
- Div Yield
44,993 Volume
- Eps
$ 116.49
Previous Close
Add Transaction
Day Range
116.29 117.48
Year Range
87.95 124.44
Want to track ADUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains?

Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains?

Addus HomeCare (ADUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks | 1 year ago
ADUS or USPH: Which Is the Better Value Stock Right Now?

ADUS or USPH: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?

Zacks | 1 year ago
Addus HomeCare (ADUS) Upgraded to Strong Buy: Here's Why

Addus HomeCare (ADUS) Upgraded to Strong Buy: Here's Why

Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 year ago
ADUS vs. USPH: Which Stock Is the Better Value Option?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
Are Investors Undervaluing Addus HomeCare (ADUS) Right Now?

Are Investors Undervaluing Addus HomeCare (ADUS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Is the Options Market Predicting a Spike in Addus HomeCare (ADUS) Stock?

Is the Options Market Predicting a Spike in Addus HomeCare (ADUS) Stock?

Investors need to pay close attention to Addus HomeCare (ADUS) stock based on the movements in the options market lately.

Zacks | 1 year ago
ADUS or USPH: Which Is the Better Value Stock Right Now?

ADUS or USPH: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?

Zacks | 1 year ago
Addus HomeCare Corporation (ADUS) Q4 2024 Earnings Call Transcript

Addus HomeCare Corporation (ADUS) Q4 2024 Earnings Call Transcript

Addus HomeCare Corporation (ADUS) Q4 2024 Earnings Call Transcript

Seekingalpha | 1 year ago
Here's What Key Metrics Tell Us About Addus HomeCare (ADUS) Q4 Earnings

Here's What Key Metrics Tell Us About Addus HomeCare (ADUS) Q4 Earnings

While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Addus HomeCare (ADUS) Q4 Earnings Match Estimates

Addus HomeCare (ADUS) Q4 Earnings Match Estimates

Addus HomeCare (ADUS) came out with quarterly earnings of $1.38 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.32 per share a year ago.

Zacks | 1 year ago
Down -16.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Addus HomeCare (ADUS)

Down -16.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Addus HomeCare (ADUS)

Addus HomeCare (ADUS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks | 1 year ago
Loading...
Load More